Cargando…
Fibrinogen production is enhanced in an in-vitro model of non-alcoholic fatty liver disease: an isolated risk factor for cardiovascular events?
BACKGROUND: Cardiovascular disease (CVD) remains the major cause of excess mortality in patients with non-alcoholic fatty liver disease (NAFLD). The aim of this study was to investigate the individual contribution of NAFLD to CVD risk factors in the absence of pathogenic influences from other comorb...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4529985/ https://www.ncbi.nlm.nih.gov/pubmed/26256740 http://dx.doi.org/10.1186/s12944-015-0069-3 |
_version_ | 1782384854012264448 |
---|---|
author | Yeung, Emily N. W. Treskes, Philipp Martin, Sarah F. Manning, Jonathan R. Dunbar, Donald R. Rogers, Sophie M. Le Bihan, Thierry Lockman, K. Ann Morley, Steven D. Hayes, Peter C. Nelson, Leonard J. Plevris, John N. |
author_facet | Yeung, Emily N. W. Treskes, Philipp Martin, Sarah F. Manning, Jonathan R. Dunbar, Donald R. Rogers, Sophie M. Le Bihan, Thierry Lockman, K. Ann Morley, Steven D. Hayes, Peter C. Nelson, Leonard J. Plevris, John N. |
author_sort | Yeung, Emily N. W. |
collection | PubMed |
description | BACKGROUND: Cardiovascular disease (CVD) remains the major cause of excess mortality in patients with non-alcoholic fatty liver disease (NAFLD). The aim of this study was to investigate the individual contribution of NAFLD to CVD risk factors in the absence of pathogenic influences from other comorbidities often found in NAFLD patients, by using an established in-vitro model of hepatic steatosis. METHODS: Histopathological events in non-alcoholic fatty liver disease were recapitulated by focused metabolic nutrient overload of hepatoblastoma C3A cells, using oleate-treated-cells and untreated controls for comparison. Microarray and proteomic data from cell culture experiments were integrated into a custom-built systems biology database and proteogenomics analysis performed. Candidate genes with significant dysregulation and concomitant changes in protein abundance were identified and STRING association and enrichment analysis performed to identify putative pathogenic pathways. RESULTS: The search strategy yielded 3 candidate genes that were specifically and significantly up-regulated in nutrient-overloaded cells compared to untreated controls: fibrinogen alpha chain (2.2 fold), fibrinogen beta chain (2.3 fold) and fibrinogen gamma chain (2.1 fold) (all rank products pfp <0.05). Fibrinogen alpha and gamma chain also demonstrated significant concomitant increases in protein abundance (3.8-fold and 2.0-fold, respectively, p <0.05). CONCLUSIONS: In-vitro modelling of NAFLD and reactive oxygen species formation in nutrient overloaded C3A cells, in the absence of pathogenic influences from other comorbidities, suggests that NAFLD is an isolated determinant of CVD. Nutrient overload-induced up-regulation of all three fibrinogen component subunits of the coagulation cascade provides a possible mechanism to explain the excess CVD mortality observed in NAFLD patients. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12944-015-0069-3) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-4529985 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-45299852015-08-10 Fibrinogen production is enhanced in an in-vitro model of non-alcoholic fatty liver disease: an isolated risk factor for cardiovascular events? Yeung, Emily N. W. Treskes, Philipp Martin, Sarah F. Manning, Jonathan R. Dunbar, Donald R. Rogers, Sophie M. Le Bihan, Thierry Lockman, K. Ann Morley, Steven D. Hayes, Peter C. Nelson, Leonard J. Plevris, John N. Lipids Health Dis Research BACKGROUND: Cardiovascular disease (CVD) remains the major cause of excess mortality in patients with non-alcoholic fatty liver disease (NAFLD). The aim of this study was to investigate the individual contribution of NAFLD to CVD risk factors in the absence of pathogenic influences from other comorbidities often found in NAFLD patients, by using an established in-vitro model of hepatic steatosis. METHODS: Histopathological events in non-alcoholic fatty liver disease were recapitulated by focused metabolic nutrient overload of hepatoblastoma C3A cells, using oleate-treated-cells and untreated controls for comparison. Microarray and proteomic data from cell culture experiments were integrated into a custom-built systems biology database and proteogenomics analysis performed. Candidate genes with significant dysregulation and concomitant changes in protein abundance were identified and STRING association and enrichment analysis performed to identify putative pathogenic pathways. RESULTS: The search strategy yielded 3 candidate genes that were specifically and significantly up-regulated in nutrient-overloaded cells compared to untreated controls: fibrinogen alpha chain (2.2 fold), fibrinogen beta chain (2.3 fold) and fibrinogen gamma chain (2.1 fold) (all rank products pfp <0.05). Fibrinogen alpha and gamma chain also demonstrated significant concomitant increases in protein abundance (3.8-fold and 2.0-fold, respectively, p <0.05). CONCLUSIONS: In-vitro modelling of NAFLD and reactive oxygen species formation in nutrient overloaded C3A cells, in the absence of pathogenic influences from other comorbidities, suggests that NAFLD is an isolated determinant of CVD. Nutrient overload-induced up-regulation of all three fibrinogen component subunits of the coagulation cascade provides a possible mechanism to explain the excess CVD mortality observed in NAFLD patients. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12944-015-0069-3) contains supplementary material, which is available to authorized users. BioMed Central 2015-08-10 /pmc/articles/PMC4529985/ /pubmed/26256740 http://dx.doi.org/10.1186/s12944-015-0069-3 Text en © Yeung et al. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Yeung, Emily N. W. Treskes, Philipp Martin, Sarah F. Manning, Jonathan R. Dunbar, Donald R. Rogers, Sophie M. Le Bihan, Thierry Lockman, K. Ann Morley, Steven D. Hayes, Peter C. Nelson, Leonard J. Plevris, John N. Fibrinogen production is enhanced in an in-vitro model of non-alcoholic fatty liver disease: an isolated risk factor for cardiovascular events? |
title | Fibrinogen production is enhanced in an in-vitro model of non-alcoholic fatty liver disease: an isolated risk factor for cardiovascular events? |
title_full | Fibrinogen production is enhanced in an in-vitro model of non-alcoholic fatty liver disease: an isolated risk factor for cardiovascular events? |
title_fullStr | Fibrinogen production is enhanced in an in-vitro model of non-alcoholic fatty liver disease: an isolated risk factor for cardiovascular events? |
title_full_unstemmed | Fibrinogen production is enhanced in an in-vitro model of non-alcoholic fatty liver disease: an isolated risk factor for cardiovascular events? |
title_short | Fibrinogen production is enhanced in an in-vitro model of non-alcoholic fatty liver disease: an isolated risk factor for cardiovascular events? |
title_sort | fibrinogen production is enhanced in an in-vitro model of non-alcoholic fatty liver disease: an isolated risk factor for cardiovascular events? |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4529985/ https://www.ncbi.nlm.nih.gov/pubmed/26256740 http://dx.doi.org/10.1186/s12944-015-0069-3 |
work_keys_str_mv | AT yeungemilynw fibrinogenproductionisenhancedinaninvitromodelofnonalcoholicfattyliverdiseaseanisolatedriskfactorforcardiovascularevents AT treskesphilipp fibrinogenproductionisenhancedinaninvitromodelofnonalcoholicfattyliverdiseaseanisolatedriskfactorforcardiovascularevents AT martinsarahf fibrinogenproductionisenhancedinaninvitromodelofnonalcoholicfattyliverdiseaseanisolatedriskfactorforcardiovascularevents AT manningjonathanr fibrinogenproductionisenhancedinaninvitromodelofnonalcoholicfattyliverdiseaseanisolatedriskfactorforcardiovascularevents AT dunbardonaldr fibrinogenproductionisenhancedinaninvitromodelofnonalcoholicfattyliverdiseaseanisolatedriskfactorforcardiovascularevents AT rogerssophiem fibrinogenproductionisenhancedinaninvitromodelofnonalcoholicfattyliverdiseaseanisolatedriskfactorforcardiovascularevents AT lebihanthierry fibrinogenproductionisenhancedinaninvitromodelofnonalcoholicfattyliverdiseaseanisolatedriskfactorforcardiovascularevents AT lockmankann fibrinogenproductionisenhancedinaninvitromodelofnonalcoholicfattyliverdiseaseanisolatedriskfactorforcardiovascularevents AT morleystevend fibrinogenproductionisenhancedinaninvitromodelofnonalcoholicfattyliverdiseaseanisolatedriskfactorforcardiovascularevents AT hayespeterc fibrinogenproductionisenhancedinaninvitromodelofnonalcoholicfattyliverdiseaseanisolatedriskfactorforcardiovascularevents AT nelsonleonardj fibrinogenproductionisenhancedinaninvitromodelofnonalcoholicfattyliverdiseaseanisolatedriskfactorforcardiovascularevents AT plevrisjohnn fibrinogenproductionisenhancedinaninvitromodelofnonalcoholicfattyliverdiseaseanisolatedriskfactorforcardiovascularevents |